Allergy Diagnostics Market Anticipates Steady 11.23% CAGR Through 2030

Allergy Diagnostics Market Overview

“The Allergy Diagnostics Market is estimated to increase at a CAGR of 11.23% from $ 6.85 Billion in 2023 to $ 11.75 billion by 2030.”

Allergy-related illnesses are prevalent worldwide, and accurate diagnosis is challenging due to the complex clinical profile of allergic disorders. An allergist must differentiate between intolerances and allergies, infectious infections and non-infectious triggers, and interpret test findings to distinguish between sensitizations and allergies.

Recent diagnostic techniques for allergies of types I and IV include allergen-specific IgE antibodies, pollen, mites, animal epithelium, food, bug poisons, and medications. These diagnostics are based on three complementary foundations in daily practice.

Provocation tests and cellular assays can be used to diagnose contact allergies, which are caused by around 3,500 triggers related to the workplace. These triggers include nickel, chromium, cobalt, fragrances, rubber, plastics, preservatives, dyes, neomycin, benzocaine, sulfonamides, quinidine, wool wax, perubalsam, eye therapeutics, light filter substances, disinfectants, pesticides, technical oils, and plants.

The diagnosis is based on the history of cutaneous exposure, symptoms, patch testing, and the discovery of a late-phase clinical reaction 6 to 48 hours to 96 hours following antigen contact.

Diagnostic testing remains a crucial tool for assessing allergic patients, but several variables must be controlled for accurate results and increased predictive values. Proficiency tests are essential for allergists to ensure accuracy, and results must be recorded for easy understanding. In vitro testing must follow the same criteria as skin testing, and ordering physicians must be familiar with lab procedures. Molecular-based allergy diagnostics are expected to become more important in evaluating allergic patients.

>>>Download Sample Report Now: https://marketreportservice.com/request-sample/allergy-diagnostics-market-54511

Allergy Diagnostics Market Segment Analysis

by Product & Service

Inhaled allergies dominate the market for allergy diagnostics and treatments due to industrialization and increased air pollution. The Allergy and Asthma Foundation of America predicts 81 million Americans will suffer from seasonal allergic rhinitis. The industry is expected to expand rapidly due to the increasing prevalence of allergic rhinitis. Drug allergies, particularly in children, are expected to grow at the fastest compound annual growth rate. Commonly linked substances include sulfonamides, antiepileptic medications, and chemotherapy treatments.

By Test Type

The projection period predicts a significant increase in demand for in-vitro allergy testing due to the increasing demand for less invasive allergy diagnostics and the rise in allergies linked to pollution.

Skin Prick Test

Skin testing is a precise and affordable method for confirming common allergies. It involves applying a drop of the allergen to the patient's skin, puncturing it with a needle, and observing the reaction within 15 minutes. If the patient is susceptible, a red, swollen, and itchy area called a "wheal" may appear, which can indicate an increased likelihood of an allergic reaction. The size of the wheal also plays a role in the test.

Intradermal Skin Test

Intradermal skin testing injects a small amount of an allergen into the epidermis, allowing doctors to evaluate the results after a certain period. If the skin prick test results are negative, the test can be used to identify medication or venom allergies. However, there are few indications for food allergy intradermal skin testing.

Market Dynamics

Drivers

• The incidence of allergic disorders is rising, and they are quite expensive.
• rising respiratory illnesses and rising pollution levels
• technological innovations in new goods
• Funding for allergy diagnostics firms has increased

Restraints

The cost of allergy diagnostic equipment is high, and there is a limited understanding of allergic illnesses.

Competitive Landscape of the Allergy Diagnostics Market Analysis

• BioMerieux SA
• Siemens Healthineers AG
• Thermo Fischer Scientific Inc
• Minaris Medical America
• Omega Diagnostics Group PLC

New Developments

20 Apr 2023 Empowering healthcare practitioners with digital tools for a more personalised approach to health.

Omega Diagnostics enhances patient reporting of test results and practitioner-patient engagement by partnering with Cirdan to develop their new digital health platform.

May 13th 2022 bioMérieux announces the CE marking of VIDAS® tests for Chikungunya virus diagnosis

bioMérieux, a world leader in the field of in vitro diagnostics, announces the CE marking of its automated tests to diagnose Chikungunya virus (CHIKV) infection on immunoassay instruments of the VIDAS.

Chikungunya virus is transmitted to humans by certain mosquitoes. Due to the significant spread of these mosquitoes throughout the world, this infection which was originally present in only tropical regions, has now been described and can be acquired locally in many countries, including recently in temperate climates like North America and Europe.

VIDAS® Anti-CHIKUNGUNYA IgM and Anti-CHIKUNGUNYA IgG are new automated tests intended as an aid in the diagnosis of Chikungunya virus infection.

Breaking News, In August 2022, STAT Medical launched its first line of products with a series of simple at-home allergy test kits that allow individuals to screen themselves for a large range of common food and respiratory allergies with a single finger prick.

Breaking News, In June 2022, Oncologica, a leading healthcare testing laboratory based in Cambridge, launched a new Allergyfocus test that helps sufferers discover what common global allergens their bodies react to.

Regional Analysis of Global Allergy Diagnostics Industry

Fastest Growing Market- Asia Pacific

Largest Market- North America

“North America currently holds the majority of the market and is expected to continue so in the forecast period.”

North America is expected to lead the allergy diagnostics market due to factors like increased allergic disorders, environmental pollution, rising healthcare spending, and expanding firm operations. The COVID-19 outbreak significantly impacted allergist practices, including allergy disease diagnosis and state-wide restrictions on non-essential medical visits. The CDC has issued instructions for medical personnel, including the use of PPE and examination of individuals suspected of COVID-19 infection.

The OECD reports that healthcare spending in the US accounted for 16.8% of total GDP in 2021. The Centres for Medicare & Medicaid Services predicts an average annual growth of 4.89% between 2021 and 2030, with 2020 spending at USD 4.1 trillion and a projected increase to USD 6.8 trillion by 2030.

The Asia Pacific region is predicted to experience the fastest compound annual growth rate, with key markets like Japan, China, and India contributing significantly. These countries are taking strategic steps to consolidate their dominance, such as Glenmark's release of Ryaltris, a nasal spray for moderate to severe allergic rhinitis, in India.

Segments Covered in the Allergy Diagnostics Market Report

By Product & Service, (USD Million)

• Consumables
• Instruments
• Services

By Test Type, (USD Million)

• In Vivo
• Skin Prick Tests
• Intradermal Skin Test
• Others
• In Vitro

By Allergen, (USD Million)

• Inhaled Allergens
• Food Allergens
• Drug Allergens
• Other Allergens

By End-use, (USD Million)

• Hospital-based Laboratories
• Diagnostic Laboratories
• Other

By Region

North America

• U.S.
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Poland
• Sweden
• Netherlands

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Indonesia
• Philippines
• Vietnam

Latin America

• Brazil
• Mexico
• Argentina
• Columbia
• Peru
• Chile

Middle East & Africa

• South Africa
• Saudi Arabia
• UAE
• Turkey
• Israel

Frequently Asked Questions

What is the expected growth rate of the Allergy Diagnostics market over the next 7 years?

Allergy Diagnostics Market is estimated to increase at a CAGR of 11.23% from $ 6.85 Billion in 2023 to $ 11.75 billion by 2030. | Report 2023 by published by Market Report Service.

Who are the major players in the Allergy Diagnostics market and what is their market share?

BioMerieux SA,,Siemens Healthineers AG,,Thermo Fischer Scientific Inc,,Minaris Medical America,,Omega Diagnostics Group PLC, are prominent players operating and dominating in the market.

Who are the top 3 Allergy Diagnostics Market Key Vendors?

BioMerieux SA,,Siemens Healthineers AG,,Thermo Fischer Scientific Inc, are key players in the Allergy Diagnostics market.

Which geographical areas dominate the worldwide market for Allergy Diagnostics?

North America region are emerging as the top regional markets for Allergy Diagnostics solutions.